Lung cancer biomarkers for the assessment of modified risk tobacco products: An oxidative stress perspective

Biomarkers

Volumn 18, Issue 3, 2013, Pages 183-195

  Lowe, Frazer J ^a   Luettich, Karsta ^a   Gregg, Evan O ^b  

^a BRITISH AMERICAN TOBACCO   (United Kingdom)

^b ENI Limited   (United Kingdom)

Author keywords

Antioxidant; Cigarette; Disease prediction; Isoprostane; MRTP; Smoking

Indexed keywords

4 HYDROXYNONENAL; 5,6 DIHYDRO 5,6 DIHYDROXYTHYMIDINE; 8 HYDROXYDEOXYGUANOSINE; 8 HYDROXYGUANINE; ANTIOXIDANT; ASCORBIC ACID; CARCINOEMBRYONIC ANTIGEN; CARCINOGEN; CAROTENOID; CATALASE; CIGARETTE SMOKE; CYTOCHROME P450 1A2; DEHYDROASCORBIC ACID; DNA; DNA BASE; GLUTATHIONE PEROXIDASE; HEMOGLOBIN; HYDROXYL RADICAL; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; ISOPROSTANE DERIVATIVE; MALONALDEHYDE; MUTAGENIC AGENT; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROTEOME; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THYMIDINE; TUMOR MARKER; UNSPECIFIC MONOOXYGENASE; VOLATILE ORGANIC COMPOUND;

ANTIOXIDANT ACTIVITY; APURINIC SITE; CANCER RISK; CHROMOSOME ABERRATION; COMET ASSAY; CYTOPATHOLOGY; DNA ADDUCT; DNA DAMAGE; DNA METHYLATION; EPIGENETICS; GENE DELETION; GENE EXPRESSION; GENE INSERTION; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; INFLAMMATION; LABORATORY TEST; LIPID PEROXIDATION; LUNG CANCER; LUNG CARCINOGENESIS; MICROARRAY ANALYSIS; MICRONUCLEUS TEST; MITOCHONDRIAL GENE; MUTAGENICITY; NONHUMAN; OXIDATIVE STRESS; PARTICULATE MATTER; PRECANCER; PROMOTER REGION; PROTEIN MODIFICATION; REPRODUCIBILITY; REVIEW; RISK ASSESSMENT; SISTER CHROMATID EXCHANGE; SMOKING; STANDARDIZATION; TOBACCO; URINE LEVEL; VITAMIN BLOOD LEVEL;

ALDEHYDES; ASCORBIC ACID; BIOLOGICAL MARKERS; CAROTENOIDS; DEHYDROASCORBIC ACID; DEOXYGUANOSINE; F2-ISOPROSTANES; HUMANS; LUNG NEOPLASMS; OXIDATIVE STRESS; RISK; SMOKING; THYMIDINE; TOBACCO PRODUCTS; TOBACCO SMOKE POLLUTION;

NICOTIANA TABACUM;

EID: 84876520238     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2013.777116     Document Type: Review

References (151)

1. Abou-Seif MA. (1996). Blood antioxidant status and urine sulfate and thiocyanate levels in smokers. J Biochem Toxicol 11: 133-8. (Pubitemid 126804266)
2. Aggett PJ, Antoine JM, Asp NG, et al. (2005). Passclaim consensus on criteria. Eur J Nutr 44: 5-30.
3. Aitio A, Cabral JR, Camus AM, et al. (1988). Evaluation of sister chromatid exchange as an indicator of sensitivity to N-ethyl-Nnitrosourea- induced carcinogenesis in rats. Teratog Carcinog Mutagen 8: 273-86.
4. Alberg A. (2002). The influence of cigarette smoking on circulating concentrations of antioxidant micronutrients. Toxicology 180: 121-37. (Pubitemid 35254069)
5. Allavena P, Garlanda C, Borrello MG, et al. (2008). Pathways connecting inflammation and cancer. Curr Opin Genet Dev 18: 3-10. (Pubitemid 351694444)
6. Ames B, Haroun L, Andrews AW, et al. (1979). The reliability of the Ames assay for the prediction of chemical carcinogenicity. Mutat Res 62: 393-9.
7. Asami S, Hirano T, Yamaguchi R, et al. (1996). Increase of a type of oxidative DNA damage, 8-hydroxyguanine, and its repair activity in human leukocytes by cigarette smoking. Cancer Res 56: 2546-9. (Pubitemid 26170692)
8. Asami S, Manabe H, Miyake J, et al. (1997). Cigarette smoking induces an increase in oxidative DNA damage, 8-hydroxydeoxyguanosine, in a central site of the human lung. Carcinogenesis 18: 1763-6. (Pubitemid 28134683)
9. Ashley DL, Burns DM, Djordjevic M, et al. (2007). The scientific basis of tobacco product regulation: report of a WHO study group. Geneva: World Health Organization.
10. Aycicek A, Ipek A. (2008). Maternal active or passive smoking causes oxidative stress in cord blood. Eur J Pediatr 167: 81-5. (Pubitemid 350159824)
11. Barbato DL, Tomei G, Tomei F, Sancini A. (2010). Traffic air pollution and oxidatively generated DNA damage: can urinary 8-oxo-7,8-dihydro-2- deoxiguanosine be considered a good biomarker? A metaanalysis. Biomarkers 15: 538-45.
12. Bartsch H, Petruzzelli S, De Flora S, et al. (1992). Carcinogen metabolism in human lung tissues and the effect of tobacco smoking: results from a case-control multicenter study on lung cancer patients. Environ Health Perspect 98: 119-24. (Pubitemid 23061792)
13. Besaratinia A, Van Schooten FJ, Schilderman PA, et al. (2001). A multibiomarker approach to study the effects of smoking on oxidative DNA damage and repair and antioxidative defense mechanisms. Carcinogenesis 22: 395-401. (Pubitemid 32203817)
14. Biomarkers Definitions Working Group. (2001). Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69: 89-95.
15. Bloomer RJ. (2007). Decreased blood antioxidant capacity and increased lipid peroxidation in young cigarette smokers compared to nonsmokers: impact of dietary intake. Nutr J 6: 36-9.
16. Bombick BR, Avalos JT, Nelson PR, et al. (1998). Comparative studies of the mutagenicity of environmental tobacco smoke from cigarettes that burn or primarily heat tobacco. Environ Mol Mutagen 31: 169-75. (Pubitemid 28188288)
17. Borrill ZL, Roy K, Vessey RS, et al. (2008). Non-invasive biomarkers and pulmonary function in smokers. Int J Chron Obstruct Pulmon Dis 3: 171-83. (Pubitemid 351523730)
18. Branton P, McAdam K, Winter D, et al. (2011). Reduction of aldehydes and hydrogen cyanide yields in mainstream cigarette smoke using an amine functionalised ion exchange resin. Chem Central J 5: 15.
19. Brown BG, Lee CK, Bombick BR, et al. (1997). Comparative study of DNA adduct formation in mice following inhalation of smoke from cigarettes that burn or primarily heat tobacco. Environ Mol Mutagen 29: 303-11. (Pubitemid 27210432)
20. Buico A, Cassino C, Ravera M, et al. (2009). Oxidative stress and total antioxidant capacity in human plasma. Redox Rep 14: 125-31.
21. Calikoglu M, Unlu A, Tamer L, et al. (2002). The levels of serum vitamin C, malonyldialdehyde and erythrocyte reduced glutathione in chronic obstructive pulmonary disease and in healthy smokers. Clin Chem Lab Med 40: 1028-31. (Pubitemid 35356021)
22. Cao G, Prior RL. (1998). Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin Chem 44: 1309-15. (Pubitemid 28283072)
23. Chance B, Sies H, Boveris A. (1979). Hydroperoxide metabolism in mammalian organs. Physiol Rev 59: 527-605. (Pubitemid 9236599)
24. Charames GS, Bapat B. (2003). Genomic instability and cancer. Curr Mol Med 3: 589-96. (Pubitemid 37236402)
25. Chau CH, Rixe O, McLeod H, Figg WD. (2008). Validation of analytic methods for biomarkers used in drug development. Clin Cancer Res 14: 5967-76.
26. Chávez J, Cano C, Souki A, et al. (2007). Effect of cigarette smoking on the oxidant/antioxidant balance in healthy subjects. Am J Ther 14: 189-93. (Pubitemid 46597659)
27. Cheng KC, Cahill DS, Kasai H, et al. (1992). 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions. J Biol Chem 267: 166-72.
28. Clayson DB. (1994). Mechanistic and other considerations in cancer prevention. Cancer Lett 83: 15-19. (Pubitemid 24253512)
29. Collins AR. (1998). Molecular epidemiology in cancer research. Mol Aspects Med 19: 359-432. (Pubitemid 29261704)
30. Collins AR. (2005). Assays for oxidative stress and antioxidant status: applications to research into the biological effectiveness of polyphenols. Am J Clin Nutr 81: 261S-7S.
31. Comstock GW, Alberg AJ, Huang HY, et al. (1997). The risk of developing lung cancer associated with antioxidants in the blood: ascorbic acid, carotenoids, alpha-tocopherol, selenium, and total peroxyl radical absorbing capacity. Cancer Epidemiol Biomarkers Prev 6: 907-16. (Pubitemid 27481639)
32. Cooke MS, Olinski R, Evans MD. (2006). Does measurement of oxidative damage to DNA have clinical significance? Clin Chim Acta 365: 30-49 (Pubitemid 43196415)
33. Czabotar PE, Lee EF, Thompson GV, et al. (2011). Mutation to bax beyond the bh3 domain disrupts interactions with pro-survival proteins and promotes apoptosis. J Biol Chem 286: 7123-31.
34. Dalaveris E, Kerenidi T, Katsabeki-Katsafli A, et al. (2009). VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer. Lung Cancer 64: 219-25.
35. Department of Health and Human Services. (2010). How tobacco smoke causes disease: the biology and behavioral basis for smokingattributable disease. A report of the surgeon general. Atlanta, GA: Centers for Disease Control and Prevention. Office on Smoking and Health.
36. DiSilvestro RA, Pacht E, Davis WB, et al. (1998). Bal fluid contains detectable superoxide dismutase 1 activity. Chest 113: 401-4. (Pubitemid 28110018)
37. Doll R, Hill AB. (1950). Smoking and carcinoma of the lung; preliminary report. Br Med J 2: 739-48.
38. Durak I, Elgün S, Kemal Bingö l N, et al. (2002). Effects of cigarette smoking with different tar content on erythrocyte oxidant/antioxidant status. Addict Biol 7: 255-8. (Pubitemid 34492963)
39. Duthie SJ, Ma A, Ross MA, Collins AR. (1996). Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes. Cancer Res 56: 1291-5. (Pubitemid 26080971)
40. Epplein M, Franke AA, Cooney RV, et al. (2009). Association of plasma micronutrient levels and urinary isoprostane with risk of lung cancer: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 18: 1962-70.
41. Ermis B, Ors R, Yildirim A, et al. (2004). Influence of smoking on maternal and neonatal serum malondialdehyde, superoxide dismutase, and glutathione peroxidase levels. Ann Clin Lab Sci 34: 405-9. (Pubitemid 40040961)
42. Ermis B, Yildirim A, Ors R, et al. (2005). Influence of smoking on serum and milk malondialdehyde, superoxide dismutase, glutathione peroxidase, and antioxidant potential levels in mothers at the postpartum seventh day. Biol Trace Elem Res 105: 27-36. (Pubitemid 41009045)
43. Esterbauer H, Schaur RJ, Zollner H. (1991). Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11: 81-128. (Pubitemid 121003917)
44. Evans J, Maccabee M, Hatahet Z, et al. (1993). Thymine ring saturation and fragmentation products: lesion bypass, misinsertion and implications for mutagenesis. Mutat Res 299: 147-56. (Pubitemid 23115154)
45. Evans MD, Saparbaev M, Cooke MS. (2010). DNA repair and the origins of urinary oxidized 20-deoxyribonucleosides. Mutagenesis 25: 433-42.
46. Fahn HJ, Wang LS, Kao SH, et al. (1998). Smoking-associated mitochondrial DNA mutations and lipid peroxidation in human lung tissues. Am J Respir Cell Mol Biol 19: 901-9.
47. Faust F, Kassie F, Knasmuller S, et al. (2004). The use of the alkaline comet assay with lymphocytes in human biomonitoring studies. Mutat Res 566: 209-29. (Pubitemid 38472028)
48. Faux SP, Tai T, Thorne D, et al. (2009). The role of oxidative stress in the biological responses of lung epithelial cells to cigarette smoke. Biomarkers 14: 90-6.
49. Food and Drug Administration. (2001). Guidance for industry: bioanalytical method validation. Rockville (MD): U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM).
50. Frost-Pineda K, Zedler BK, Oliveri D, et al. (2008). Short-term clinical exposure evaluation of a third-generation electrically heated cigarette smoking system (EHCSS) in adult smokers. Regul Toxicol Pharmacol 52: 104-10.
51. Frost-Pineda K, Liang Q, Liu J, et al. (2011). Biomarkers of potential harm among adult smokers and nonsmokers in the total exposure study. Nicotine Tob Res 13: 182-93.
52. Gaber A, Tamoi M, Takeda T, et al. (2001). Nadph-dependent glutathione peroxidase-like proteins (gpx-1, gpx-2) reduce unsaturated fatty acid hydroperoxides in synechocystis pcc 6803. FEBS Lett 499: 32-6. (Pubitemid 32539315)
53. Gallicchio L, Boyd K, Matanoski G, et al. (2008). Carotenoids and the risk of developing lung cancer: a systematic review. Am J Clin Nutr 88: 372-83.
54. Gold LS, Manley NB, Ames BN. (1992). Extrapolation of carcinogenicity between species: qualitative and quantitative factors. Risk Anal 12: 579-88. (Pubitemid 23050545)
55. Goodman GE, Schaffer S, Omenn GS, et al. (2003). The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial. Cancer Epidemiol Biomarkers Prev 12: 518-26. (Pubitemid 36713646)
56. Greabu M, Totan A, Battino M, et al. (2008). Cigarette smoke effect on total salivary antioxidant capacity, salivary glutathione peroxidase and gamma-glutamyltransferase activity. Biofactors 33: 129-36.
57. Gregg EO, Fisher AL, Lowe F, et al. (2006). An approach to the validation of biomarkers of harm for use in a tobacco context. Regul Toxicol Pharmacol 44: 262-7.
58. Gregg E, Hill C, Hollywood M, et al. (2004). The UK smoke constituents testing study. Summary of results and comparison with other studies. Beiträge Tabakforsch Int Contrib Tobacco Res 21: 117-38. (Pubitemid 39051811)
59. Gregory EM, Fridovich I. (1973). Oxygen toxicity and the superoxide dismutase. J Bacteriol 114: 1193-7.
60. Hahn WC, Weinberg RA. (2002). Rules for making human tumor cells. N Engl J Med 347: 1593-603. (Pubitemid 35315841)
61. Halliwell B, Whiteman M. (2004). Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol 142: 231-55. (Pubitemid 38746160)
62. Hanahan D, Weinberg RA. (2000). The hallmarks of cancer. Cell 100: 57-70. (Pubitemid 30046295)
63. Harju T, Kaarteenaho-Wiik R, Sirviö R, et al. (2004). Manganese superoxide dismutase is increased in the airways of smokers' lungs. Eur Respir J 24: 765-71. (Pubitemid 39504429)
64. Harman SM, Liang L, Tsitouras PD, et al. (2003). Urinary excretion of three nucleic acid oxidation adducts and isoprostane f(2)alpha measured by liquid chromatography-mass spectrometry in smokers, ex-smokers, and nonsmokers. Free Radic Biol Med 35: 1301-9. (Pubitemid 37357255)
65. Hatsukami DK, Benowitz NL, Rennard SI, et al. (2006). Biomarkers to assess the utility of potential reduced exposure tobacco products. Nicotine Tob Res 8: 169-91. (Pubitemid 43675073)
66. Hilbert J, Mohsenin V. (1996). Adaptation of lung antioxidants to cigarette smoking in humans. Chest 110: 916-20. (Pubitemid 26347603)
67. Holick CN, Michaud DS, Stolzenberg-Solomon R, et al. (2002). Dietary carotenoids, serum beta-carotene, and retinol and risk of lung cancer in the alpha-tocopherol, beta-carotene cohort study. Am J Epidemiol 156: 536-47. (Pubitemid 35001196)
68. Hu W, Feng Z, Eveleigh J, et al. (2002). The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma. Carcinogenesis 23: 1781-9. (Pubitemid 35355927)
69. Hulea SA, Olinescu R, Nita S, et al. (1995). Cigarette smoking causes biochemical changes in blood that are suggestive of oxidative stress: a case-control study. J Environ Pathol Toxicol Oncol 14: 173-80. (Pubitemid 27058363)
70. Institute of Medicine. (2001). Clearing the smoke: assessing the science base for tobacco harm reduction. Washington, DC: National Academy Press.
71. Institute of Medicine. (2010). Evaluation of biomarkers and surrogate endpoints in chronic disease. Washington, DC: National Academies Press.
72. Institute of Medicine. (2012). Scientific standards for studies on modified risk tobacco products. Washington, DC: The National Academies Press.
73. Isik B, Ceylan A, Isik R. (2007). Oxidative stress in smokers and nonsmokers. Inhal Toxicol 19: 767-9.
74. Ito Y, Wakai K, Suzuki K, et al.; JACC Study Group. (2005). Lung cancer mortality and serum levels of carotenoids, retinol, tocopherols, and folic acid in men and women: a case-control study nested in the JACC study. J Epidemiol 15: S140-9. (Pubitemid 41410096)
75. Janssen LJ. (2001). Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol 280: L1067-82. (Pubitemid 32553245)
76. Jemal A, Bray F, Center MM, et al. (2011). Global cancer statistics. CA Cancer J Clin 61: 69-90.
77. Keaney Jr JF, Larson MG, Vasan RS, et al.; Framingham Study. (2003). Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham study. Arterioscler Thromb Vasc Biol 23: 434-9. (Pubitemid 36337219)
78. Kim SH, Kim JS, Shin HS, Keen CL. (2003). Influence of smoking on markers of oxidative stress and serum mineral concentrations in teenage girls in Korea. Nutrition 19: 240-3. (Pubitemid 36279462)
79. Knaapen AM, Gungor N, Schins RPF, et al. (2006). Neutrophils and respiratory tract DNA damage and mutagenesis: a review. Mutagenesis 21: 225-36. (Pubitemid 44543334)
80. Kristenson M, Kucinskiene Z, Schafer-Elinder L, et al. (2003). Lower serum levels of beta-carotene in lithuanian men are accompanied by higher urinary excretion of the oxidative DNA adduct, 8-hydroxydeoxyguanosine. The Livicordia study. Nutrition 19: 11-15. (Pubitemid 36044479)
81. Kuiper HC, Bruno RS, Traber MG, Stevens JF. (2011). Vitamin C supplementation lowers urinary levels of 4-hydroperoxy-2-nonenal metabolites in humans. Free Radic Biol Med 50: 848-53.
82. Kuiper HC, Langsdorf BL, Miranda CL, et al. (2010). Quantitation of mercapturic acid conjugates of 4-hydroxy-2-nonenal and 4-oxo-2-nonenal metabolites in a smoking cessation study. Free Radic Biol Med 48: 65-72.
83. Lee JW, Devanarayan V, Barrett YC, et al. (2006). Fit-for-purpose method development and validation for successful biomarker measurement. Pharm Res 23: 312-28. (Pubitemid 43237862)
84. Lee BM, Lee SK, Kim HS. (1998). Inhibition of oxidative DNA damage, 8-ohdg, and carbonyl contents in smokers treated with antioxidants (vitamin e, vitamin c, beta-carotene and red ginseng). Cancer Lett 132: 219-27. (Pubitemid 28535208)
85. Liang Y, Wei P, Duke RW, et al. (2003). Quantification of 8-isoprostaglandin-f(2alpha) and 2,3-dinor-8-iso-prostaglandin-f(2alpha) in human urine using liquid chromatography-tandem mass spectrometry. Free Radic Biol Med 34: 409-18. (Pubitemid 36140165)
86. Liebler DC, Reed DJ. (1999). Free radical defence and repair mechanisms. In: Wallace KB, ed. Free radical toxicology. New York: Publisher Press, 490-5.
87. Life Sciences Research Office. (2007). Scientific methods to evaluate potential reduces-risk tobacco products. Bethesda (MD): Life Sciences Research Office.
88. Liu C, DeGrandpré Y, Porter A, et al. (2011a). The use of a novel tobacco treatment process to reduce toxicant yields in cigarette smoke. Food Chem Toxicol 49: 1904-17.
89. Liu X, Jakubowski M, Hunt JL. (2011b). Kras gene mutation in colorectal cancer is correlated with increased proliferation and spontaneous apoptosis. Am J Clin Pathol 135: 245-52.
90. Lodovici M, Caldini S, Luceri C, et al. (2005). Active and passive smoking and lifestyle determinants of 8-oxo-7,8-dihydro-20-deoxyguanosine levels in human leukocyte DNA. Cancer Epidemiol Biomarkers Prev 14: 2975-7. (Pubitemid 43068833)
91. Loft S, Poulsen HE. (1999). Markers of oxidative damage to DNA: antioxidants and molecular damage. Methods Enzymol 300: 166-84.
92. Loft S, Svoboda P, Kawai K, et al. (2012). Association between 8-oxo-7,8-dihydroguanine excretion and risk of lung cancer in a prospective study. Free Radic Biol Med 1;52: 167-72.
93. Loft S, Vistisen K, Ewertz M, et al. (1992). Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis 13: 2241-7. (Pubitemid 23022963)
94. Lowe FJ, Gregg EO, McEwan M. (2009). Evaluation of biomarkers of exposure and potential harm in smokers, former smokers and neversmokers. Clin Chem Lab Med 47: 311-20.
95. Lykkesfeldt J. (2007a). Ascorbate and dehydroascorbic acid as reliable biomarkers of oxidative stress: analytical reproducibility and longterm stability of plasma samples subjected to acidic deproteinization. Cancer Epidemiol Biomarkers Prev 16: 2513-16. (Pubitemid 351196391)
96. Lykkesfeldt J. (2007b). Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking. Clin Chim Acta 380: 50-8. (Pubitemid 46498044)
97. Lykkesfeldt J, Loft S, Nielsen JB, Poulsen HE. (1997). Ascorbic acid and dehydroascorbic acid as biomarkers of oxidative stress caused by smoking. Am J Clin Nutr 65: 959-63. (Pubitemid 27152611)
98. Lykkesfeldt J, Viscovich M, Poulsen HE. (2003). Ascorbic acid recycling in human erythrocytes is induced by smoking in vivo. Free Radic Biol Med 35: 1439-47. (Pubitemid 37452468)
99. Makropoulos W, Kocher K, Heintz B, et al. (2000). Urinary thymidine glycol as a biomarker for oxidative stress after kidney transplantation. Ren Fail 22: 499-510. (Pubitemid 30441645)
100. Marnett LJ. (2000). Oxyradicals and DNA damage. Carcinogenesis 21: 361-70. (Pubitemid 30137921)
101. McAdam KG, Gregg EO, Liu C, et al. (2011). The use of a novel tobacco-substitute sheet and smoke dilution to reduce toxicant yields in cigarette smoke. Food Chem Toxicol 49: 1684-96.
102. Meier BM, Shelley D. (2006). The fourth pillar of the framework convention on tobacco control: harm reduction and the international human right to health. Public Health Rep 121: 494-500. (Pubitemid 44520676)
103. Michaud DS, Feskanich D, Rimm EB, et al. (2000). Intake of specific carotenoids and risk of lung cancer in 2 prospective US cohorts. Am J Clin Nutr 72: 990-7.
104. Montuschi P, Collins JV, Ciabattoni G, et al. (2000). Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med 162: 1175-7.
105. Mooney LA, Madsen AM, Tang D, et al. (2005). Antioxidant vitamin supplementation reduces benzo(a)pyrene-DNA adducts and potential cancer risk in female smokers. Cancer Epidemiol Biomarkers Prev 14: 237-42. (Pubitemid 40165307)
106. Morrow JD, Frei B, Longmire AW, et al. (1995). Increase in circulating products of lipid peroxidation (f2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 332: 1198-203.
107. Morrow JD, Harris TM, Roberts LJ. (1990a). Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids. Anal Biochem 184: 1-10. (Pubitemid 20029736)
108. Morrow JD, Hill KE, Burk RF, et al. (1990b). A series of prostaglandin f2-like compounds are produced in vivo in humans by a noncyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 87: 9383-7. (Pubitemid 120030630)
109. Munnia A, Bonassi S, Verna A, et al. (2006). Bronchial malondialdehyde DNA adducts, tobacco smoking, and lung cancer. Free Radic Biol Med 41: 1499-505. (Pubitemid 44472630)
110. Oguogho A, Lupattelli G, Palumbo B, Sinzinger H. (2000). Isoprostanes quickly normalize after quitting cigarette smoking in healthy adults. Vasa 29: 103-5. (Pubitemid 30353672)
111. Orhan H, Evelo CTA, Sahin G. (2005). Erythrocyte antioxidant defense response against cigarette smoking in humans-the glutathione s-transferase vulnerability. J Biochem Mol Toxicol 19: 226-33. (Pubitemid 41318430)
112. Ozguner F, Koyu A, Cesur G. (2005). Active smoking causes oxidative stress and decreases blood melatonin levels. Toxicol Ind Health 21: 21-6. (Pubitemid 40835711)
113. Pannuru P, Vaddi DR, Kindinti RR, Varadacharyulu N. (2011). Increased erythrocyte antioxidant status protects against smoking induced hemolysis in moderate smokers. Hum Exp Toxicol 30: 1475-81.
114. Pilger A, Rudiger HW. (2006). 8-hydroxy-20-deoxyguanosine as a marker of oxidative DNA damage related to occupational and environmental exposures. Int Arch Occup Environ Health 80: 1-15. (Pubitemid 44489988)
115. Pinhal D, Gontijo AMdMC, Reyes VAV, Salvadori DMF. (2006). Viable human buccal mucosa cells do not yield typical nucleoids: impacts on the single-cell gel electrophoresis/comet assay. Environ Mol Mutagen 47: 117-26.
116. Polidori MC, Mecocci P, Stahl W, Sies H. (2003). Cigarette smoking cessation increases plasma levels of several antioxidant micronutrients and improves resistance towards oxidative challenge. Br J Nutr 90: 147-50. (Pubitemid 36903412)
117. Pourcelot S, Faure H, Firoozi F, et al. (1999). Urinary 8-oxo-7,8-dihydro-20-deoxyguanosine and 5-(hydroxymethyl) uracil in smokers. Free Radic Res 30: 173-80. (Pubitemid 29195122)
118. Pryor WA, Dooley MM, Church DF. (1985). Mechanisms of cigarette smoke toxicity: the inactivation of human alpha-1-proteinase inhibitor by nitric oxide/isoprene mixtures in air. Chem Biol Interact 54: 171-83. (Pubitemid 15006069)
119. Rahman I, van Schadewijk AA, Crowther AJ, et al. (2002). 4-hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166: 490-5.
120. Reilly M, Delanty N, Lawson JA, FitzGerald GA. (1996). Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 94: 19-25. (Pubitemid 126426395)
121. Russell MAH. (1976). Low-tar medium-nicotine cigarettes: a new approach to safer smoking. BMJ 1: 1430-3.
122. Sahu RP, Batra S, Kandala PK, et al. (2011). The role of k-ras gene mutation in trail-induced apoptosis in pancreatic and lung cancer cell lines. Cancer Chemother Pharmacol 67: 481-7.
123. Sarkar M, Kapur S, Frost-Pineda K, et al. (2008). Evaluation of biomarkers of exposure to selected cigarette smoke constituents in adult smokers switched to carbon-filtered cigarettes in short-term and long-term clinical studies. Nicotine Tob Res 10: 1761-72.
124. Serafini M, Villano D, Spera G, Pellegrini N. (2006). Redox molecules and cancer prevention: the importance of understanding the role of the antioxidant network. Nutr Cancer 56: 232-40. (Pubitemid 46417684)
125. Shibutani S, Takeshita M, Grollman AP. (1991). Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature 349: 431-4. (Pubitemid 21926107)
126. Smith CJ, McKarns SC, Davis RA, et al. (1996). Human urine mutagenicity study comparing cigarettes which burn or primarily heat tobacco. Mutat Res 361: 1-9. (Pubitemid 26290698)
127. Smith CJ, Perfetti TA, King JA. (2006). Perspectives on pulmonary inflammation and lung cancer risk in cigarette smokers. Inhal Toxicol 18: 667-77.
128. Somogyi A, Rosta K, Pusztai P, et al. (2007). Antioxidant measurements. Physiol Meas 28: 41-55.
129. Stephens JW, Khanolkar MP, Bain SC. (2009). The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis 202: 321-9.
130. Szeto Y, Lee A, Benzie I, Obied H. (2012). Optimized noninvasive procedures to measure DNA damage in comet assay. Hum Exp Toxicol 31: 1144-50.
131. Tanriverdi H, Evrengul H, Kuru O, et al. (2006). Cigarette smoking induced oxidative stress may impair endothelial function and coronary blood flow in angiographically normal coronary arteries. Circ J 70: 593-9.
132. Thier R, Brüning T, Kocher K, et al. (1999). Determination of urinary thymidine glycol using affinity chromatography, HPLC and postcolumn reaction detection: a biomarker of oxidative DNA damage upon kidney transplantation. Arch Toxicol 73: 479-84. (Pubitemid 30010250)
133. Tudek B, Swoboda M, Kowalczyk P, Olinski R. (2006). Modulation of oxidative DNA damage repair by the diet, inflammation and neoplastic transformation. J Physiol Pharmacol 57: 33-49. (Pubitemid 46548789)
134. Valavanidis A, Vlachogianni T, Fiotakis K. (2009). Tobacco smoke: involvement of reactive oxygen species and stable free radicals in mechanisms of oxidative damage, carcinogenesis and synergistic effects with other respirable particles. Int J Environ Res Public Health 6: 445-62.
135. Valko M, Izakovic M, Mazur M, et al. (2004). Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 266: 37-56. (Pubitemid 39562306)
136. van Zeeland AA, de Groot AJ, Hall J, Donato F. (1999). 8-hydroxydeoxyguanosine in DNA from leukocytes of healthy adults: relationship with cigarette smoking, environmental tobacco smoke, alcohol and coffee consumption. Mutat Res 439: 249-57. (Pubitemid 29094817)
137. Vasan RS. (2006). Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation 113: 2335-62. (Pubitemid 43947980)
138. Vineis P, Husgafvel-Pursiainen K. (2005). Air pollution and cancer: biomarker studies in human populations. Carcinogenesis 26: 1846-55. (Pubitemid 41631257)
139. Voulgaridou GP, Anestopoulos I, Franco R, et al. (2011). DNA damage induced by endogenous aldehydes: current state of knowledge. Mutat Res 711: 13-27.
140. Wallace SS. (2002). Biological consequences of free radical-damaged DNA bases. Free Radic Biol Med 33: 1-14. (Pubitemid 34681001)
141. World Health Organization Classification of Tumours. (2004). Pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon: IARC Press.
142. Wright ME, Mayne ST, Swanson CA, et al. (2003). Dietary carotenoids, vegetables, and lung cancer risk in women: the Missouri women's health study (United States). Cancer Causes Control 14: 85-96. (Pubitemid 36403273)
143. Wynder EL, Graham EA. (1950). Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma; a study of 684 proved cases. J Am Med Assoc 143: 329-36.
144. Yagi O, Aoshiba K, Nagai A. (2006). Activation of nuclear factor-kappab in airway epithelial cells in patients with chronic obstructive pulmonary disease. Respiration 73: 610-16. (Pubitemid 44481477)
145. Yamanaka K, Mizoi M, Tachikawa M, et al. (2003). Oxidative DNA damage following exposure to dimethylarsinous iodide: the formation of cis-thymine glycol. Toxicol Lett 143: 145-53. (Pubitemid 36577162)
146. Yao QH, Mei SR, Weng QF, et al. (2004). Determination of urinary oxidative DNA damage marker 8-hydroxy-20-deoxyguanosine and the association with cigarette smoking. Talanta 63: 617-23.
147. Young IS. (2001). Measurement of total antioxidant capacity. J Clin Pathol 54: 339. (Pubitemid 32458129)
148. Yuan JM, Stram DO, Arakawa K, et al. (2003). Dietary cryptoxanthin and reduced risk of lung cancer: the Singapore Chinese health study. Cancer Epidemiol Biomarkers Prev 12: 890-8. (Pubitemid 37151525)
149. Zedler BK, Kinser R, Oey J, et al. (2006). Biomarkers of exposure and potential harm in adult smokers of 3-7 mg tar yield (federal trade commission) cigarettes and in adult non-smokers. Biomarkers 11: 201-20. (Pubitemid 43879067)
150. Zhang XY, Tan YL, Zhou DF, et al. (2007). Nicotine dependence, symptoms and oxidative stress in male patients with schizophrenia. Neuropsychopharmacology 32: 2020-4. (Pubitemid 47258513)
151. Zwingmann IH, Welle IJ, van Herwijnen M, et al. (1998). Oxidative DNA damage and cytogenetic effects in flight engineers exposed to cosmic radiation. Environ Mol Mutagen 32: 121-9. (Pubitemid 28465323)